[1]
Siegel, R.L.; Miller, K.D.; Fedewa, S.A.; Ahnen, D.J.; Meester, R.G.; Barzi, A.; Jemal, A. Colorectal cancer statistics. CA Cancer J. Clin., 2017, 67(3), 177-193.
[2]
Bénard, F.; Barkun, A.N.; Martel, M.; von Renteln, D. Systematic review of colorectal cancer screening guidelines for average-risk adults: Summarizing the current global recommendations. World J. Gastroenterol., 2018, 24(1), 124.
[3]
Tummala, S.; Gowthamarajan, K.; Kumar, M.S.; Wadhwani, A. Oxaliplatin immuno hybrid nanoparticles for active targeting: An approach for enhanced apoptotic activity and drug delivery to colorectal tumors. Drug Deliv., 2016, 23(5), 1773-1787.
[4]
Jia, X.; Han, Y.; Pei, M.; Zhao, X.; Tian, K.; Zhou, T.; Liu, P. Multi-functionalized hyaluronic acid nanogels crosslinked with carbon dots as dual receptor-mediated targeting tumor theranostics. Carbohydr. Polym., 2016, 152, 391-397.
[5]
Wei, M.; Gao, Y.; Li, X.; Serpe, M.J. Stimuli-responsive polymers and their applications. Polym. Chem., 2017, 8(1), 127-143.
[6]
Neufeld, L.; Bianco-Peled, H. Pectin-chitosan physical hydrogels as potential drug delivery vehicles. Int. J. Biol. Macromol., 2017, 101, 852-861.
[7]
Seeli, D.S.; Prabaharan, M. Guar gum oleate-graft-poly (methacrylic acid) hydrogel as a colon-specific controlled drug delivery carrier. Carbohydr. Polym., 2017, 158, 51-57.
[8]
Kaith, B.; Jindal, R.; Kumar, V.; Bhatti, M.S. Optimal response surface design of gum tragacanth-based poly [(acrylic acid)-co-acrylamide] IPN hydrogel for the controlled release of the antihypertensive drug losartan potassium. RSC Advances, 2014, 4(75), 39822-39829.
[9]
Kurdtabar, M.; Koutenaee, R.N.; Bardajee, G.R. Synthesis and characterization of a novel pH-responsive nanocomposite hydrogel based on chitosan for targeted drug release. J. Polym. Res., 2018, 25(5), 119.
[10]
Haider, A.; Kortz, U.; Joshi, S.A.; Iqbal, J. Polyethyleneimine‐polyoxometalate‐based supramolecular self‐assembled pH‐responsive hydrogels: Formulation and in vitro evaluation. ChemistrySelect, 2017, 2(21), 5905-5912.
[11]
Pourjavadi, A.; Barzegar, S.; Zeidabadi, F. Synthesis and properties of biodegradable hydrogels of κ-carrageenan grafted acrylic acid-co-2-acrylamido-2-methylpropanesulfonic acid as candidates for drug delivery systems. React. Funct. Polym., 2007, 67(7), 644-654.
[12]
Ito, H.; Yamaguchi, H.; Fujikawa, A.; Tanaka, N.; Furugen, A.; Miyamori, K.; Takahashi, N.; Ogura, J.; Kobayashi, M.; Yamada, T. A full validated hydrophilic interaction liquid chromatography-tandem mass spectrometric method for the quantification of oxaliplatin in human plasma ultrafiltrates. J. Pharm. Biomed. Anal., 2012, 71, 99-103.
[13]
Anwar, H.; Ahmad, M.; Minhas, M.U.; Rehmani, S. Alginate-polyvinyl alcohol based interpenetrating polymer network for prolonged drug therapy, optimization and in-vitro characterization. Carbohydr. Polym., 2017, 166, 183-194.
[14]
Gámiz‐González, M.A.; Edlund, U.; Vidaurre, A.; Gomez Ribelles, J.L. Synthesis of highly swellable hydrogels of water‐soluble carboxymethyl chitosan and poly (ethylene glycol). Polym. Int., 2017, 66(11), 1624-1632.
[15]
Tanuma, H.; Kiuchi, H.; Kai, W.; Yazawa, K.; Inoue, Y. Characterization and enzymatic degradation of PEG‐cross‐linked chitosan hydrogel films. J. Appl. Polym. Sci., 2009, 114(3), 1902-1907.
[16]
Gorgieva, S.; Kokol, V. Preparation, characterization, and in vitro enzymatic degradation of chitosan‐gelatine hydrogel scaffolds as potential biomaterials. J. Biomed. Mater. Res. A, 2012, 100(7), 1655-1667.
[17]
Jankaew, R.; Rodkate, N.; Lamlertthon, S.; Rutnakornpituk, B.; Wichai, U.; Ross, G.; Rutnakornpituk, M. “Smart” carboxymethylchitosan hydrogels crosslinked with poly (N-isopropylacrylamide) and poly (acrylic acid) for controlled drug release. Polym. Test., 2015, 42, 26-36.
[18]
Food; Administration, D. Guidance for industry: Estimating the
maximum safe starting dose in initial clinical trials for therapeutics
in adult healthy volunteers. Center for Drug Evaluation and Research
(CDER), 2005, 7.
[19]
Haider, A.; Kortz, U.; Afridi, S.; Sohail, M.; Joshi, S.A.; Iqbal, J. Novel pH responsive supramolecular hydrogels of chitosan hydrochloride and polyoxometalate: In-vitro, in-vivo and preliminary safety evaluation. Int. J. Pharm., 2017, 533(1), 125-137.
[20]
Barkat, K.; Ahmad, M.; Usman Minhas, M.; Khalid, I.; Nasir, B. Development and characterization of pH‐responsive polyethylene glycol‐co‐poly (methacrylic acid) polymeric network system for colon target delivery of oxaliplatin: Its acute oral toxicity study. Adv. Polym. Technol., 2017, 37(6), 1806-1822.
[21]
(a) Neto, C.D.T.; Giacometti, J.; Job, A.; Ferreira, F.; Fonseca, J.; Pereira, M. Thermal analysis of chitosan based networks. Carbohydr. Polym., 2005, 62(2), 97-103.
(b) Sohail, M.; Ahmad, M.; Minhas, M.U.; Rashid, H.; Khalid, I. Development and in vitro evaluation of high molecular weight chitosan based polymeric composites for controlled delivery of valsartan. Adv. Polym. Technol., 2016, 35(4), 361-368.
[22]
Malik, N.S.; Ahmad, M.; Minhas, M.U. Cross-linked β-cyclodextrin and carboxymethyl cellulose hydrogels for controlled drug delivery of acyclovir. PLoS One, 2017, 12(2), e0172727.
[23]
Rajpoot, K.; Jain, S.K. Colorectal cancer-targeted delivery of oxaliplatin via folic acid-grafted solid lipid nanoparticles: Preparation, optimization, and in vitro evaluation. Artif. Cells Nanomed. Biotechnol., 2017, 46(6), 1236-1247.
[24]
Hu, X.; Wei, W.; Qi, X.; Yu, H.; Feng, L.; Li, J.; Wang, S.; Zhang, J.; Dong, W. Preparation and characterization of a novel pH-sensitive Salecan-g-poly (acrylic acid) hydrogel for controlled release of doxorubicin. J. Mater. Chem. B, 2015, 3(13), 2685-2697.
[25]
Azmeera, V.; Adhikary, P.; Krishnamoorthi, S. Synthesis and characterization of graft copolymer of dextran and 2-acrylamido-2-methylpropane sulphonic acid. Int. J. Carbohydr. Chem., 2012, 2012, 7.
[26]
Khan, S.; Ranjha, N.M. Effect of degree of cross-linking on swelling and on drug release of low viscous chitosan/poly (vinyl alcohol) hydrogels. Polym. Bull., 2014, 71(8), 2133-2158.
[27]
Ranjha, N.M.; Ayub, G.; Naseem, S.; Ansari, M.T. Preparation and characterization of hybrid pH-sensitive hydrogels of chitosan-co-acrylic acid for controlled release of verapamil. J. Mater. Sci. Mater. Med., 2010, 21(10), 2805-2816.
[28]
Khanum, H.; Ullah, K.; Murtaza, G.; Khan, S.A. Fabrication and in
vitro characterization of HPMC-g-poly (AMPS) hydrogels loaded
with loxoprofen sodium. Int. J. Biol. Macromol, 2018, 120(Pt B),
1624-1631.
[29]
Khalid, I.; Ahmad, M.; Usman Minhas, M.; Barkat, K.; Sohail, M. Cross‐linked sodium alginate‐g‐poly (acrylic acid) structure: A potential hydrogel network for controlled delivery of loxoprofen sodium. Adv. Polym. Technol., 2016, 37(4), 985-995.
[30]
Samanta, H.S.; Ray, S.K. Controlled release of tinidazole and theophylline from chitosan based composite hydrogels. Carbohydr. Polym., 2014, 106, 109-120.
[31]
Sohail, M.; Ahmad, M.; Minhas, M.U.; Ali, L.; Khalid, I.; Rashid, H. Controlled delivery of valsartan by cross-linked polymeric matrices: Synthesis, in vitro and in vivo evaluation. Int. J. Pharm., 2015, 487(1-2), 110-119.
[32]
Devi, N.; Narzary, A. Release dynamics of brufen from a drug-loaded polymer hydrogel containing polyvinyl alcohol, 2-acrylamide-2-methylpropane sulfonic acid and acrylamide. Int. J. Polym. Mater., 2012, 61(11), 821-833.
[33]
Azizullah; Nisar-ur-Rehman; Liu, W.; Haider, A.; Kortz, U.; Sohail, M.; Joshi, S.A.; Iqbal, J. Novel gelatin-polyoxometalate based self-assembled pH responsive hydrogels: Formulation and in vitro characterization. Des. Monomers Polym., 2016, 19(8), 697-705.
[34]
Kulish, E.; Volodina, V.; Kolesov, S.; Zaikov, G. Enzymatic degradation of chitosan films by collagenase. Polym. Sci. Ser. B, 2006, 48(5), 244-246.
[35]
McBane, J.E.; Vulesevic, B.; Padavan, D.T.; McEwan, K.A.; Korbutt, G.S.; Suuronen, E.J. Evaluation of a collagen-chitosan hydrogel for potential use as a pro-angiogenic site for islet transplantation. PLoS One, 2013, 8(10), e77538.
[36]
Tummala, S.; Kumar, M.S.; Pindiprolu, S.K. Improved anti-tumor activity of oxaliplatin by encapsulating in anti-DR5 targeted gold nanoparticles. Drug Deliv., 2016, 23(9), 3505-3519.